Understanding how gut bacteria stability affects inflammatory bowel disease
Official title: The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease
Funded at Icahn School of Medicine at Mount Sinai · NIH-11083621 · Data updated 2026-11-12
This study is looking at how the balance of gut bacteria affects people with Inflammatory Bowel Disease (IBD), like Ulcerative Colitis and Crohn's Disease, by comparing their gut samples to those of healthy individuals and tracking changes in bacteria after treatments to help improve their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 4, 2019 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $641,450 |
| NIH project number | 5R01DK112978-07 |
| Project ID | NIH-11083621 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Inflammatory Bowel Disease, including Ulcerative Colitis and Crohn's Disease.
✕Less likely to help
Patients without a diagnosis of Inflammatory Bowel Disease or those with other unrelated gastrointestinal conditions may not benefit from this research.
What this research studies
This research investigates the role of gut microbiota stability in patients with Inflammatory Bowel Disease (IBD), which includes conditions like Ulcerative Colitis and Crohn's Disease. Over a period of five years, researchers will collect and analyze fecal samples from individuals with IBD and healthy controls to identify differences in gut bacteria. They will also study patients who have undergone fecal microbiota transplantation to see how the gut microbiota changes over time and its impact on disease remission. The goal is to understand how certain bacteria contribute to inflammation and disease progression.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with inflammatory bowel disease by identifying key bacterial strains that influence disease stability and remission.
How similar studies have gone: Previous research has shown promising results in understanding the gut microbiome's role in inflammatory bowel diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Faith, Jeremiah James — Icahn School of Medicine at Mount Sinai
- Study coordinator: Faith, Jeremiah James
Related research
Other NIH-funded projects on the same topics.
-
Processed foods, gut bacteria, and immune defenses in inflammatory bowel disease
This project tests whether an ultra‑processed food–style diet changes gut bacteria and weakens immune defenses in people at risk for inflammatory bowel disease.
-
Gut bacteria stability in ulcerative colitis and Crohn’s disease
Researchers are tracking gut bacteria over several years in people with ulcerative colitis and Crohn’s disease (and healthy volunteers) to see whether long-term bacterial stability links to flares and outcomes after fecal transplants.
-
Gut microbes, fiber in your diet, and inflammatory bowel disease
This grant explores how dietary fiber and gut bacteria influence inflammatory bowel disease and related inflammation in people and models.
-
How processed diets and gut bacteria affect inflammatory bowel disease
This study is looking at how eating a lot of processed foods might affect gut bacteria and the immune system, which could increase the risk of inflammatory bowel disease (IBD), and it aims to find ways to improve diets to help prevent or reduce IBD.
-
Gut microbiome and Parkinson's disease: how gut bugs relate to symptoms and progression
A multi-year study will look at gut bacteria and related markers in people with Parkinson’s disease to understand how the gut-brain connection may influence symptoms and progression.
-
Gut-Brain Axis in Parkinson’s Disease: biomarkers and procedures to track progression
A patient-focused program to study how gut health and the brain interact in Parkinson’s disease using biomarkers and clinical procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.